Monday, December 3, 2018

Corporate governance issue hits Sun Pharma; should you sell or buy on dips?

Corporate governance issue hits Sun Pharma; should you sell or buy on dips? Most brokerages maintained their reduce or hold ratings on Sun Pharma, while some of them slashed their target price

from Moneycontrol Business News https://ift.tt/2AMFFH0

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...